by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK. Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food...
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project Posted on February 10, 2023 Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater research and clinical practice in children to...
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
Development Bank of Wales ramping up tech equity deals since the lockdown Posted on September 12, 2022 The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic...
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm Posted on July 14, 2021 Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market....
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics Posted on April 27, 2022 The £1 million grant will support the development of the first Oral Food Challenges (OFCs) for paediatric patients to diagnose...
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans Posted on April 21, 2020 Reacta Biotech raises £1.25m to secure MHRA site license Once achieved, the license will enable significantly expanded production of its Oral Food...